A new prognostic tool for CLL: CLL-IPI
The importance of considering a CLL patient's tumor lysis risk status
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
Prognostic markers for CLL - how do they help determine who gets which treatment?
Big data on efficacy and toxicity levels for ibrutinib in CLL